Progress toward liquid biopsies in pediatric solid tumors
- 13 December 2019
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 38 (4) , 553-571
Abstract
Pediatric solid tumors have long been known to shed tumor cells, DNA, RNA, and proteins into the blood. Recent technological advances have allowed for improved capture and analysis of these typically scant circulating materials. Efforts are ongoing to develop “liquid biopsy” assays as minimally invasive tools to address diagnostic, prognostic, and disease monitoring needs in childhood cancer care. Applying these highly sensitive technologies to serial liquid biopsies is expected to advance understanding of tumor biology, heterogeneity, and evolution over the course of therapy, thus opening new avenues for personalized therapy. In this review, we outline the latest technologies available for liquid biopsies and describe the methods, pitfalls, and benefits of the assays that are being developed for children with extracranial solid tumors. We discuss what has been learned in several of the most common pediatric solid tumors including neuroblastoma, sarcoma, Wilms tumor, and hepatoblastoma and highlight promising future directions for the field.Keywords
This publication has 211 references indexed in Scilit:
- Tet-mediated covalent labelling of 5-methylcytosine for its genome-wide detection and sequencingNature Communications, 2013
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectBritish Journal of Cancer, 2012
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian GenomeCell, 2012
- Circulating microRNAs: Association with disease and potential use as biomarkersCritical Reviews in Oncology/Hematology, 2011
- Determination of 17q gain in patients with neuroblastoma by analysis of circulating DNAPediatric Blood & Cancer, 2011
- Twenty years of follow‐up of survivors of childhood osteosarcomaCancer, 2010
- Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsGenes, Chromosomes and Cancer, 2010
- Influence of neuroblastoma stage on serum‐based detection of MYCN amplificationPediatric Blood & Cancer, 2009
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005